European Active Surveillance Study (EURAS)
Launched by CENTER FOR EPIDEMIOLOGY AND HEALTH RESEARCH, GERMANY · Mar 13, 2006
Trial Information
Current as of June 28, 2025
Completed
Keywords
ClinConnect Summary
Active surveillance using valid epidemiologic study designs is desirable for any new product, because adverse effects may occur that have not yet been identified in pre-marketing studies.
The EURAS study investigates the safety of oral contraceptives with a large cohort of women attending offices of prescribing physicians. Its primary objective will be to compare incidence rates of adverse events in users of so-called new OCs and users of other OCs. The study is conducted as a phase IV commitment to the European Drug Authorities.
The combined cohort will include 50,000 to 60,000 women rec...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women starting OC use or women switching OCs
- • Women willing to participate in the active surveillance for several years
- Exclusion Criteria:
- • Women who have contraindications for OC use
About Center For Epidemiology And Health Research, Germany
The Center for Epidemiology and Health Research in Germany is a leading institution dedicated to advancing public health through rigorous epidemiological studies and clinical research. With a focus on understanding the determinants of health and disease, the center conducts innovative trials that aim to inform public health policies and improve health outcomes. Committed to fostering collaboration among researchers, healthcare professionals, and policymakers, the center employs state-of-the-art methodologies to generate evidence-based insights that address pressing health challenges. Through its comprehensive research initiatives, the center plays a pivotal role in enhancing the scientific foundation for health interventions and promoting community well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Juergen C Dinger, MD, PhD
Principal Investigator
Center for Epidemiology and Health Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials